FibroScan Service Contract Costs in Australia — and What Clinics Do When the Bill Arrives
The FibroScan device purchase is the visible cost. The annual service contract — $11,000–$14,000 per year — is what catches clinics off guard. Here is what you are actually paying for, and what the alternatives look like.
MSAC Application 1797 — rejected early 2025
The MBS funding application for FibroScan/VCTE was rejected by MSAC. There is currently no Medicare rebate for liver elastography in Australia, regardless of system. The out-of-pocket model applies to FibroScan and all alternatives. Full MSAC rejection analysis →
The Service Contract Lock-In Model
FibroScan is sold on a standard medical device model: a device purchase, a warranty period, and then an annual service contract to maintain coverage. This is not unusual in medical equipment — but the combination of FibroScan's relatively high service contract pricing, the additional XL probe cost for any clinic serving a high-BMI patient population, and the MSAC 1797 rejection (no MBS rebate to offset costs) has made the economics much harder for Australian clinics to justify in 2025.
The service contract covers preventive maintenance, software updates, and parts/labour for repairs. What it does not cover: the XL probe (required for BMI >30 patients), consumables, or operator training for new staff. Clinics report that renewal rates push upward over the device lifetime.
The Hidden Cost: Failed Scans in High-BMI Patients
The service contract is visible and predictable. The failed scan problem is less visible but potentially more costly. In a clinic where 30–40% of patients have BMI >30 — entirely typical for an Australian MAFLD practice — the M probe's 20–25% failure rate in that cohort means 1 in 4 of those patients leaves without a usable result. That patient visit generated zero clinical value and needs to be rescheduled (if they return) or referred elsewhere.
If a clinic performs 200 MAFLD-indicated scans per year, with 40% in BMI >30, that is 80 high-BMI scans — at 20% failure, 16 failed scans per year. At $150 per scan, that is $2,400 in unrecoverable revenue, plus the clinical cost of unresolved patient pathways. Over 3 years: approximately $7,200 in failed scans on top of service contract costs.
3-Year Total Cost of Ownership: FibroScan vs iLivTouch
| Cost Component | FibroScan (VCTE) | iLivTouch (Guided TE) |
|---|---|---|
| Device purchase (base) | $38,000–$45,000 | $28,000–$35,000 |
| XL probe (high-BMI patients) | $8,000–$12,000 additional | Included — universal probe |
| Annual service contract | $11,000–$14,000/yr | $4,000–$6,000/yr |
| 3-year service total | $33,000–$42,000 | $12,000–$18,000 |
| 3-year TCO (device + service) | $79,000–$99,000 | $40,000–$53,000 |
| Failed scan cost (20–25% in BMI >30) | Unrecoverable — patient leaves without result | ~5–7% failure rate — guided placement reduces repeats |
| MBS rebate status (2025) | Rejected — MSAC 1797 | Rejected — MSAC 1797 (same position) |
Indicative figures based on published Echosens pricing and Elastography Australia commercial terms. Contact for current pricing in your configuration.
Frequently Asked Questions
How much does a FibroScan service contract cost in Australia?
FibroScan annual service contracts in Australia typically cost $11,000–$14,000 per year for the standard M-probe configuration. The XL probe (required for high-BMI patients, BMI >30) is an additional capital purchase and adds to annual service costs. Over a 5-year device life, total service spend is typically $55,000–$70,000 on top of the original device purchase price.
What does a FibroScan service contract include?
FibroScan service contracts from Echosens typically include preventive maintenance, software updates, and parts/labour for device repairs. They do not typically include the XL probe (sold separately), consumables, or training for new staff. The service contract is typically required to maintain warranty-equivalent coverage after the initial warranty period expires.
What happens if I don't renew my FibroScan service contract?
Without a service contract, FibroScan repairs are charged at time-and-materials rates, which can be significantly higher per incident than amortised contract costs. Software updates may also be limited. Many clinics renew contracts as the alternative (unrestricted repair billing) is unpredictable. This creates ongoing lock-in after the initial device purchase.
Is there a FibroScan alternative with lower total cost of ownership?
Yes. Guided TE systems such as iLivTouch offer significantly lower total cost of ownership over a 3–5 year period. A single universal probe eliminates the XL probe surcharge. Service contracts are typically priced lower. In a 3-year TCO model, iLivTouch costs approximately $60,000–$70,000 all-in versus $90,000–$110,000 for FibroScan with XL probe and service. The clinical performance advantage of guided acquisition also reduces the cost of failed/repeated scans.
Get a full TCO comparison for your clinic
Based on your patient volume and BMI mix, we can model the 3-year cost difference between FibroScan and iLivTouch — including the cost of failed scans.
Request a TCO analysis